Successful treatment of HIV-associated multicentric Castleman's disease and multiple organ failure with rituximab and supportive care: a case report
暂无分享，去创建一个
R. Johns | P. Isaacson | M. Lipman | S. Shaw | J. Cleverley | B. Agarwal | K. Cwynarski | T. Doyle
[1] C. Boucher,et al. HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review , 2009, AIDS.
[2] F. Kortüm,et al. Successful treatment of multicentric Castleman's disease with combined immunochemotherapy in an AIDS patient with multiorgan failure , 2008, Leukemia.
[3] S. Montoto,et al. Brief Communication: Rituximab in HIV-Associated Multicentric Castleman Disease , 2007, Annals of Internal Medicine.
[4] H. O. Oudemans-van Straaten,et al. Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing. , 2007, Journal of critical care.
[5] M. Górgolas,et al. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease , 2006, Annals of Hematology.
[6] G. Ossenkoppele,et al. Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care , 2005, European journal of haematology.
[7] V. Calvez,et al. Rituximab therapy for HIV-associated Castleman disease. , 2003, Blood.
[8] B. Régnier,et al. Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU. , 1998, Chest.
[9] J. Decruyenaere,et al. Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit , 2005, Intensive Care Medicine.
[10] M. Levy,et al. Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock , 2022 .